Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine: Evidence for FGF-2 release from cells not extracellular matrix

Vascular Pharmacology

Volumn 38, Issue 4, 2002, Pages 229-237

  Chai, Yuh Cherng ^a   Binion, David G ^a,b   Macklis, Roger ^a   Chisolm III, Guy M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Atherosclerosis; Fibroblast growth factor; Inflammation; Lysophospholipids; PAF like lipids

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; LYSOPHOSPHATIDYLCHOLINE; METALLOPROTEINASE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANIMALS; CELL DEATH; CELL DIVISION; CELL MEMBRANE PERMEABILITY; CYTOPLASM; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; METALLOENDOPEPTIDASES; MUSCLE, SMOOTH, VASCULAR; OXIDATION-REDUCTION; RABBITS;

EID: 0036556738     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(02)00173-8     Document Type: Article

References (54)

1. Ananyeva N.M., Tjurmin A.V., Berliner J.A., Chisolm G.M., Liau G., Winkles J.A., Haudenschild C.C. Oxidized LDL mediates the release of fibroblast growth factor-1. Arterioscler. Thromb. Vasc. Biol. 17:1997;445-453.
2. Auge N., Andrieu N., Negre-Salvayre A., Thiers J.C., Levade T., Salvayre R. The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J. Biol. Chem. 271:1996;19251-19255.
3. Auge N., Escargueil-Blanc I., Lajoie-Mazenc I., Suc I., Andrieu-Abadie N., Pieraggi M.T., Chatelut M., Thiers J.C., Jaffrezou J.P., Laurent G., Levade T., Negre-Salvayre A., Salvayre R. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J. Biol. Chem. 273:1998;12893-12900.
4. Auge N., Nikolova-Karakashian M., Carpentier S., Parthasarathy S., Negre-Salvayre A., Salvayre R., Merrill A.H. Jr., Levade T. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J. Biol. Chem. 274:1999;21533-21538.
5. Auge N., Negre-Salvayre A., Salvayre R., Levade T. Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog. Lipid Res. 39:2000;207-229.
6. Balagopalakrishna C., Bhunia A.K., Rifkind J.M., Chatterjee S. Minimally modified low density lipoproteins induce aortic smooth muscle cell proliferation via the activation of mitogen activated protein kinase. Mol. Cell. Biochem. 170:1997;85-89.
7. Bass D.A., Parce J.W., Dechatelet L.R., Szejda P., Seeds M.C., Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130:1983;1910-1917.
8. Berliner J., Leitinger N., Watson A., Huber J., Fogelman A., Navab M. Oxidized lipids in atherogenesis: formation, destruction and action. Thromb. Haemost. 78:1997;195-199.
9. Bhunia A.K., Han H., Snowden A., Chatterjee S. Lactosylceramide stimulates Ras-GTP loading, kinases (MEK, Raf), p44 mitogen-activated protein kinase, and c-fos expression in human aortic smooth muscle cells. J. Biol. Chem. 271:1996;10660-10666.
10. Bhunia A.K., Han H., Snowden A., Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J. Biol. Chem. 272:1997;15642-15649.
11. Burdon R.H., Gill V., Rice-Evans C. Cell proliferation and oxidative stress. Free Radic. Res. Commun. 7:1989;149-159.
12. Chai Y.C., Howe P.H., DiCorleto P.E., Chisolm G.M. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells: evidence for release of FGF-2. J. Biol. Chem. 271:1996;17791-17797.
13. Chai Y.C., Binion D.G., Chisolm G.M. Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H1830-H1838.
14. Chatterjee S. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Mol. Cell. Biochem. 111:1992;143-147.
15. Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler. Thromb. Vasc. Biol. 18:1998;1523-1533.
16. Chatterjee S., Ghosh N. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation. Glycobiology. 6:1996;303-311.
17. 44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells. Glycobiology. 7:1997;703-710.
18. Chisolm G.M., Chai Y. Regulation of cell growth by oxidized LDL. Free Radic. Biol. Med. 28:2000;1697-1707.
19. Chisolm G.M., Penn M.S. Oxidized lipoproteins and atherosclerosis. Fuster V., Ross R., Topol E.J. Atherosclerosis and Coronary Artery Disease. 1996;129-149 Raven Press, New York.
20. Chisolm G.M., Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28:2000;1815-1826.
21. Colles S.M., Chisolm G.M. Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events. J. Lipid Res. 41:2000;1188-1198.
22. Faham S., Linhardt R.J., Rees D.C. Diversity does make a difference: fibroblast growth factor-heparin interactions. Curr. Opin. Struct. Biol. 8:1998;578-586.
23. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell. 104:2001;503-516.
24. Gospodarowicz D., Ill C. Extracellular matrix and control of proliferation of vascular endothelial cells. J. Clin. Invest. 65:1980;1351-1364.
25. Heery J.M., Kozak M., Stafforini D.M., Jones D.A., Zimmerman G.A., McIntyre T.M., Prescott S.M. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J. Clin. Invest. 96:1995;2322-2330.
26. Heinecke J.W. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler. Thromb. Vasc. Biol. 21:2001;1261-1264.
27. 2 for vascular smooth muscle cells is mediated by an increase of the affinity of basic fibroblast growth factor for its receptor. FEBS Lett. 395:1996;43-47.
28. Hessler J.R., Robertson A.L. Jr., Chisolm G.M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 32:1979;213-229.
29. Hessler J.R., Morel D.W., Lewis L.J., Chisolm G.M. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3:1983;215-222.
30. Kranenburg O., Moolenaar W.H. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene. 20:2001;1540-1546.
31. Lafont A.M., Chai Y.C., Cornhill J.F., Whitlow P.L., Howe P.H., Chisolm G.M. Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J. Clin. Invest. 95:1995;1018-1025.
32. Libby P. Changing concepts of atherogenesis. J. Intern. Med. 247:2000;349-358.
33. Marathe G.K., Harrison K.A., Murphy R.C., Prescott S.M., Zimmerman G.A., McIntyre T.M. Bioactive phospholipid oxidation products. Free Radic. Biol. Med. 28:2000;1762-1770.
34. Mashima R., Witting P.K., Stocker R. Oxidants and antioxidants in atherosclerosis. Curr. Opin. Lipidol. 12:2001;411-418.
35. Morel D.W., Hessler J.R., Chisolm G.M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J. Lipid Res. 24:1983;1070-1076.
36. Murrell G.A., Francis M.J., Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265:1990;659-665.
37. Navab M., Berliner J.A., Subbanagounder G., Hama S., Lusis A.J., Castellani L.W., Reddy S., Shih D., Shi W., Watson A.D., Van Lenten B.J., Vora D., Fogelman A.M. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 21:2001;481-488.
38. Parthasarathy S., Khan-Merchant N., Penumetcha M., Khan B.V., Santanam N. Did the antioxidant trials fail to validate the oxidation hypothesis? Curr. Atheroscler. Rep. 3:2001;392-398.
39. Rao G.N., Berk B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70:1992;593-599.
40. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke. 29:1998;1020-1030.
41. Ruef J., Rao G.N., Li F., Bode C., Patterson C., Bhatnagar A., Runge M.S. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation. 97:1998;1071-1078.
42. Sakai M., Kobori S., Miyazaki A., Horiuchi S. Macrophage proliferation in atherosclerosis. Curr. Opin. Lipidol. 11:2000;503-509.
43. Shirhatti V., Krishna G. A simple and sensitive method for monitoring drug-induced cell injury in culture cells. Anal. Biochem. 147:1985;410-418.
44. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U. S. A. 81:1984;3883-3887.
45. Stiko A., Regnstrom J., Shah K., Cercek B., Nilsson J. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis. Arterioscler. Thromb. Vasc. Biol. 16:1996;194-200.
46. Stiko-Rahm A., Hultgardh-Nilsson A., Regnstrom J., Hamsten A., Nilsson J. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler. Thromb. 12:1992;1099-1109.
47. Vlodavsky I., Miao H.Q., Medalion B., Danagher P., Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 15:1996;177-186.
48. Weiss R.H., Maduri M. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J. Biol. Chem. 268:1993;5724-5727.
49. Winkles J.A., Friesel R., Alberts G.F., Janat M.F., Liau G. Elevated expression of basic fibroblast growth factor in an immortalized rabbit smooth muscle cell line. Am. J. Pathol. 143:1993;518-527.
50. Witztum J.L., Berliner J.A. Oxidized phospholipids and isoprostanes in atherosclerosis. Curr. Opin. Lipidol. 9:1998;441-448.
51. Witztum J.L., Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc. Med. 11:2001;93-102.
52. Wroblewski F., LaDue J.S. Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90:1955;210-213.
53. Zettler M.E., Pierce G.N. Growth-promoting effects of oxidized low density lipoprotein. Can J. Cardiol. 17:2001;73-79.
54. Zwijsen R.M., Japenga S.C., Heijen A.M.P., Van den Bos R.C., Koeman J.H. Induction of platelet-derived growth factor chain A gene expression in human smooth muscle cells by oxidized low density lipoproteins. Biochem. Biophys. Res. Commun. 186:1992;1410-1416.